{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T01:08:55Z","timestamp":1786756135300,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02821"],"award-info":[{"award-number":["2018-02821"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Research Fund for Neuromuscular Disorders in West Sweden"},{"name":"The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement","award":["ALFGBG-872571"],"award-info":[{"award-number":["ALFGBG-872571"]}]},{"name":"The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement","award":["ALFGBG-965898"],"award-info":[{"award-number":["ALFGBG-965898"]}]},{"name":"The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement","award":["ALFGBG-926621"],"award-info":[{"award-number":["ALFGBG-926621"]}]},{"name":"The Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement","award":["ALFGBG-716821"],"award-info":[{"award-number":["ALFGBG-716821"]}]},{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Inclusion body myositis (IBM), an inflammatory myopathy with progressive weakness without efficient treatment, typically presents after 45\u00a0years of age and younger patients are sparsely studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a population-based study during a 33-year period, 142 patients with IBM were identified in western Sweden. Six patients fell outside the European Neuromuscular Centre 2011 criteria for IBM due to young age at symptom onset, verified by a muscle biopsy\u2009&lt;\u200950\u00a0years of age. These were defined as early-onset IBM and included in this study. Medical records, muscle strength, comorbidities, muscle biopsies, and nuclear- and mitochondrial DNA were examined and compared with patients with IBM and age matched controls from the same population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median age at symptom onset was 36 (range 34\u201345) years and at diagnosis 43 (range 38\u201358) years. Four patients were deceased at a median age of 59 (range 50\u201375) years. The median survival from diagnosis was 14 (range 10\u201318) years. The prevalence December 31 2017 was 1.2 per million inhabitants and the mean incidence 0.12 patients per million inhabitants and year. The mean decline in quadriceps strength\u2009\u00b1\u20091 standard deviation was 1.21\u2009\u00b1\u20090.2 Newton or 0.91\u2009\u00b1\u20090.2% per month and correlated to time from diagnosis (p\u2009&lt;\u20090.001). Five patients had swallowing difficulties. All patients displayed mitochondrial changes in muscle including cytochrome c oxidase deficiency and the mitochondrial DNA mutation load was high.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Early-onset IBM is a severe disease, causing progressive muscle weakness, high muscle mitochondrial DNA mutation load and a reduced cumulative survival in young and middle-aged individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-023-11878-w","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T12:02:23Z","timestamp":1690459343000},"page":"5483-5492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inclusion body myositis with early onset: a population-based study"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-4492","authenticated-orcid":false,"given":"Ulrika","family":"Lindgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-4185","authenticated-orcid":false,"given":"Carola","family":"Hedberg-Oldfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-9817","authenticated-orcid":false,"given":"Rille","family":"Pullerits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-3597","authenticated-orcid":false,"given":"Christopher","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-7397","authenticated-orcid":false,"given":"Anders","family":"Oldfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"11878_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","volume":"23","author":"MR Rose","year":"2013","unstructured":"Rose MR, Amato AA, Engel A, Hilton-Jones D (2013) 188th ENMC International Workshop: Inclusion body myositis, 2\u20134 December 2011, Naarden, The Netherlands. Neuromuscul Disord 23:1044\u20131055. https:\/\/doi.org\/10.1016\/j.nmd.2013.08.007","journal-title":"Neuromuscul Disord"},{"key":"11878_CR2","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s00415-005-0884-y","volume":"252","author":"UA Badrising","year":"2005","unstructured":"Badrising UA, Maat-Schieman ML, van Houwelingen JC, van Doorn PA, van Duinen SG, van Engelen BG et al (2005) Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol 252:1448\u20131454. https:\/\/doi.org\/10.1007\/s00415-005-0884-y","journal-title":"J Neurol"},{"key":"11878_CR3","doi-asserted-by":"publisher","first-page":"e1406","DOI":"10.1212\/WNL.0000000000206777","volume":"100","author":"EH Michelle","year":"2023","unstructured":"Michelle EH, Pinal-Fernandez I, Casal-Dominguez M, Albayda J, Paik JJ, Tiniakou E et al (2023) Clinical subgroups and factors associated with progression in patients with inclusion body myositis. Neurology 100:e1406\u2013e1417. https:\/\/doi.org\/10.1212\/WNL.0000000000206777","journal-title":"Neurology"},{"key":"11878_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/00005792-200109000-00006","volume":"80","author":"KJ Felice","year":"2001","unstructured":"Felice KJ, North WA (2001) Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period. Medicine (Baltimore) 80:320\u2013327. https:\/\/doi.org\/10.1097\/00005792-200109000-00006","journal-title":"Medicine (Baltimore)"},{"key":"11878_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/brain\/112.3.727","volume":"112","author":"BP Lotz","year":"1989","unstructured":"Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ (1989) Inclusion body myositis. Observations in 40 patients. Brain 112:727\u2013747. https:\/\/doi.org\/10.1093\/brain\/112.3.727","journal-title":"Brain"},{"key":"11878_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ana.26412","volume":"92","author":"U Lindgren","year":"2022","unstructured":"Lindgren U, Pullerits R, Lindberg C, Oldfors A (2022) Epidemiology, survival, and clinical characteristics of inclusion body myositis. Ann Neurol 92:201\u2013212. https:\/\/doi.org\/10.1002\/ana.26412","journal-title":"Ann Neurol"},{"key":"11878_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29:1\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2007.05.002","journal-title":"J Autoimmun"},{"key":"11878_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/02841861003782017","volume":"49","author":"G Engholm","year":"2010","unstructured":"Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A et al (2010) NORDCAN\u2014a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 49:725\u2013736. https:\/\/doi.org\/10.3109\/02841861003782017","journal-title":"Acta Oncol"},{"key":"11878_CR9","unstructured":"Danckert B, Ferlay J, Engholm G, Hansen H, Johannesen T, Khan S et al (2019) NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries: association of the Nordic Cancer Registries. Danish Cancer Society; 2019 Version 8.2. http:\/\/www.ancr.nu. Accessed 24 Feb 2020"},{"key":"11878_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12931","volume":"31","author":"C Hedberg-Oldfors","year":"2021","unstructured":"Hedberg-Oldfors C, Lindgren U, Basu S, Visuttijai K, Lindberg C, Falkenberg M et al (2021) Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing. Brain Pathol 31:e12931. https:\/\/doi.org\/10.1111\/bpa.12931","journal-title":"Brain Pathol"},{"key":"11878_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009242","volume":"16","author":"S Basu","year":"2020","unstructured":"Basu S, Xie X, Uhler JP, Hedberg-Oldfors C, Milenkovic D, Baris OR et al (2020) Accurate mapping of mitochondrial DNA deletions and duplications using deep sequencing. PLoS Genet 16:e1009242. https:\/\/doi.org\/10.1371\/journal.pgen.1009242","journal-title":"PLoS Genet"},{"key":"11878_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005306","volume":"11","author":"J Ding","year":"2015","unstructured":"Ding J, Sidore C, Butler TJ, Wing MK, Qian Y, Meirelles O et al (2015) Assessing mitochondrial DNA variation and copy number in lymphocytes of ~2,000 Sardinians using tailored sequencing analysis tools. PLoS Genet 11:e1005306. https:\/\/doi.org\/10.1371\/journal.pgen.1005306","journal-title":"PLoS Genet"},{"key":"11878_CR13","doi-asserted-by":"crossref","unstructured":"Statistics Sweden. https:\/\/www.scb.se. Accessed 17 Aug 2022","DOI":"10.1787\/540fd3de-en"},{"key":"11878_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"11878_CR15","volume-title":"Muscle biopsy\u2014a practical approach","author":"V Dubowitz","year":"2021","unstructured":"Dubowitz V, Sewry C, Oldfors A (2021) Muscle biopsy\u2014a practical approach, 5th edn. Elsevier, Amsterdam","edition":"5"},{"key":"11878_CR16","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/rheumatology\/keab716","volume":"61","author":"E Naddaf","year":"2022","unstructured":"Naddaf E, Shelly S, Mandrekar J, Chamberlain AM, Hoffman EM, Ernste FC et al (2022) Survival and associated comorbidities in inclusion body myositis. Rheumatology (Oxford) 61:2016\u20132024. https:\/\/doi.org\/10.1093\/rheumatology\/keab716","journal-title":"Rheumatology (Oxford)"},{"key":"11878_CR17","doi-asserted-by":"publisher","first-page":"e2653","DOI":"10.1212\/WNL.0000000000012004","volume":"96","author":"S Shelly","year":"2021","unstructured":"Shelly S, Mielke MM, Mandrekar J, Milone M, Ernste FC, Naddaf E et al (2021) Epidemiology and natural history of inclusion body myositis: a 40-year population-based study. Neurology 96:e2653\u2013e2661. https:\/\/doi.org\/10.1212\/WNL.0000000000012004","journal-title":"Neurology"},{"key":"11878_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","volume":"45","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg O (2015) Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. Semin Arthritis Rheum 45:301\u2013308. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.005","journal-title":"Semin Arthritis Rheum"},{"key":"11878_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR et al (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705\u2013713. https:\/\/doi.org\/10.1002\/ana.410380504","journal-title":"Ann Neurol"},{"key":"11878_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/mus.27716","volume":"66","author":"M Alamr","year":"2022","unstructured":"Alamr M, Pinto MV, Naddaf E (2022) Atypical presentations of inclusion body myositis: clinical characteristics and long-term outcomes. Muscle Nerve 66:686\u2013693. https:\/\/doi.org\/10.1002\/mus.27716","journal-title":"Muscle Nerve"},{"key":"11878_CR21","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/brain\/awr213","volume":"134","author":"O Benveniste","year":"2011","unstructured":"Benveniste O, Guiguet M, Freebody J, Dubourg O, Squier W, Maisonobe T et al (2011) Long-term observational study of sporadic inclusion body myositis. Brain 134:3176\u20133184. https:\/\/doi.org\/10.1093\/brain\/awr213","journal-title":"Brain"},{"key":"11878_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02493524","volume":"6","author":"S Lindgren","year":"1991","unstructured":"Lindgren S, Janzon L (1991) Prevalence of swallowing complaints and clinical findings among 50\u201379-year-old men and women in an urban population. Dysphagia 6:187\u2013192. https:\/\/doi.org\/10.1007\/BF02493524","journal-title":"Dysphagia"},{"key":"11878_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-0404.2011.01584.x","volume":"125","author":"C Lindberg","year":"2012","unstructured":"Lindberg C, Oldfors A (2012) Prognosis and prognostic factors in sporadic inclusion body myositis. Acta Neurol Scand 125:353\u2013358. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01584.x","journal-title":"Acta Neurol Scand"},{"key":"11878_CR24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/ene.12627","volume":"22","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjarne J et al (2015) High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur J Neurol 22:672-e41. https:\/\/doi.org\/10.1111\/ene.12627","journal-title":"Eur J Neurol"},{"key":"11878_CR25","first-page":"374","volume-title":"Recent advances in myology","author":"S Carpenter","year":"1975","unstructured":"Carpenter S, Karpati G, Eisen A (1975) A morphologic study in polymyositis: clues to pathogenesis of different types. In: Bradley W (ed) Recent advances in myology. Excerpta Medica, Amsterdam, pp 374\u20139"},{"key":"11878_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/brain\/116.2.325","volume":"116","author":"A Oldfors","year":"1993","unstructured":"Oldfors A, Larsson NG, Lindberg C, Holme E (1993) Mitochondrial DNA deletions in inclusion body myositis. Brain 116:325\u201336","journal-title":"Brain"},{"key":"11878_CR27","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.lpm.2010.11.024","volume":"40","author":"V Askanas","year":"2011","unstructured":"Askanas V, Engel WK (2011) Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-beta42 oligomers and phosphorylated tau. Presse Med 40:e219-35. https:\/\/doi.org\/10.1016\/j.lpm.2010.11.024","journal-title":"Presse Med"},{"key":"11878_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.nmd.2014.12.010","volume":"25","author":"U Lindgren","year":"2015","unstructured":"Lindgren U, Roos S, Hedberg Oldfors C, Moslemi AR, Lindberg C, Oldfors A (2015) Mitochondrial pathology in inclusion body myositis. Neuromuscul Disord 25:281\u20138. https:\/\/doi.org\/10.1016\/j.nmd.2014.12.010","journal-title":"Neuromuscul Disord"},{"key":"11878_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.547638","volume":"11","author":"TD Jeppesen","year":"2020","unstructured":"Jeppesen TD, Duno M, Vissing J (2020) Mutation load of single, large-scale deletions of mtDNA in mitotic and postmitotic tissues. Front Genet 11:547638. https:\/\/doi.org\/10.3389\/fgene.2020.547638","journal-title":"Front Genet"},{"key":"11878_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/nan.12149","volume":"41","author":"KA Rygiel","year":"2015","unstructured":"Rygiel KA, Miller J, Grady JP, Rocha MC, Taylor RW, Turnbull DM (2015) Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathol Appl Neurobiol 41:288\u2013303. https:\/\/doi.org\/10.1111\/nan.12149","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11878-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11878-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11878-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:05:28Z","timestamp":1697274328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11878-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["11878"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11878-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the regional ethic review board in Gothenburg, Sweden, approval number 633-15 and T215-16, and conducted according to the Declaration of Helsinki. All living patients gave informed consent to participate prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}}]}}